Birth Defect Lawyers for Topamax Side Effects
Marc J. Bern & Partners and its professional team are reviewing potential lawsuits on behalf of children born with birth defects and malformations after their mothers used the epilepsy and migraine medication Topamax while pregnant.
Topamax side effects may increase the risk of an unborn child developing an oral cleft or other major birth defects, which may have been avoided if adequate warnings were provided by the drug maker. Compensation may be available for children through a Topamax lawsuit for birth defects, such as:
- Cleft Palate
- Cleft Lip
- Genital Defects
- Other Birth Defects or Malformations
Although information was available that use of Topamax during pregnancy may cause birth malformations or defects, the manufacturers failed to adequately research the potential Topamax problems. Request a free consultation about a Topamax birth defect lawsuit.
TOPAMAX CLEFT LIP AND CLEFT PALATE SIDE EFFECTS
Marc J. Bern & Partners and its professional team are investigating potential Topamax lawsuits throughout the United States on behalf of children who have experienced birth defects or malformations after the mother was given the medication while pregnant.
Topamax, known generically as topiramate, was first introduced in 1979 by McNeil Pharmaceutical, a division of Johnson & Johnson. Versions of generic Topamax became available in September 2006.
The medications are approved for treatment of epilepsy and migraine headaches, but are also often prescribed off-label to treat bipolar disorder.
Research has linked side effects of Topamax to a risk of cleft lip and cleft palate, a class of birth defects known as oral cleft defects. Use of the medication during the first trimester, before many women even know they are pregnant, may cause these serious and potentially debilitating malformations and birth defects from Topamax.
In July 2008, a small study linked the use of Topamax while pregnant to an increased risk of birth defects. Researcher found that babies born to women who used Topamax had a cleft lip or cleft palate at a rate 11 times higher than would be expected in the general population.
In March 2011, the FDA announced that they were requiring new warnings about the risk of oral cleft birth defects from Topamax. Data from the North American Antiepileptic Drug (AED) Pregnancy Registry found that infants exposed to Topamax during the first trimester experienced a 1.4% prevalence of oral clefts, compared with a prevalence of 0.38% to 0.55% for infants exposed to other antiepileptic drugs.
Manufacturers of the medication knew or should have known about the potential risk of Topamax problems for unborn children, yet failed to adequately research the side effects of topiramate or warn about the risk of a cleft lip or cleft palate from Topamax.
If proper warnings had been provided, women who were planning to become pregnant or those not practicing birth control may have been able to take a different medication during pregnancy, as not all epilepsy drugs have the same risk of birth defects as Topamax.
TOPAMAX CLASS ACTION ATTORNEYS
Marc J. Bern & Partners and its professional team are reviewing potential claims for children who may be entitled to compensation through a Topamax cleft lip lawsuit, Topamax cleft palate lawsuit or claim for another birth defect. The potential Topamax class action lawsuits are also being evaluated.
To determine if you or a family member may be eligible to pursue a case, request a free consultation and claim evaluation with one of our Topamax attorneys. All cases are reviewed on a contingency fee basis, which means that there are no fees unless a recovery is obtained.